Chemokines comprise a family of structurally homologous, intercellular molecular signals that induce migration and other cellular responses, including adhesion, activation, differentiation, proliferation and survival [1] [2] [3] [4] . Chemokine effects are mediated by classical G-protein-coupled receptors (GPCRs) 1, 2 . Additionally, chemokines ligate atypical chemokine receptors (ACKRs) 5, 6 . ACKRs are structurally similar to GPCRs but do not couple to G proteins and therefore fail to induce the full spectrum of downstream intracellular signals that characterize GPCRs 7, 8 . However ACKRs may transport, present or scavenge chemokines and thus, by different means, effectively regulate chemokine availability in tissue microenvironments [9] [10] [11] [12] . ACKR1, also known as Duffy antigen receptor for chemokines (or DARC), binds more than 20 different CC and CXC chemokines 13, 14 , and has been ascribed a unique cell expression profile in cerebellar neurons, venular endothelial cells and erythrocytes 13, 14 . In endothelial cells, ACKR1 transports and presents chemokines 9 . ACKR1 on erythrocytes has been shown to regulate chemokine concentrations in plasma by functioning as both a chemokine sink and a reservoir [15] [16] [17] , and to bind Plasmodium vivax and Plasmodium knowlesi, thus allowing these parasites to invade the erythrocytes 18, 19 .
Divergent paths of human evolution and adaptations to geographically restricted microbial pathogens have resulted in the development of distinctive functions of the immune system that characterize people of different ethnicities 20, 21 . Under physiological conditions, individuals of African ancestry have low blood neutrophil counts 22 . Such 'ethnic neutropenia' has been directly linked with the allelic variant rs2814778(G) of ACKR1, which is hugely prevalent in Africa, but the mechanism underlying this association remained unexplored 23 . Individuals of African ancestry who are homozygous for the rs2814778(G) allele of ACKR1 do not express ACKR1 on erythrocytes 24, 25 . This 'Duffy-negative' phenotype is caused by a 1-nt substitution within the promoter sequence of ACKR1, which disrupts the binding site for the erythroid transcription factor GATA-1 and leads to the selective loss of ACKR1 expression in erythrocytes but not in endothelium 26, 27 . Because erythrocytes are terminally differentiated anuclear cells with no transcription and limited translation 28 , the expression of ACKR1 might first occur during the earlier stages of A r t i c l e s erythroid cell development in the bone marrow (BM). We therefore sought to determine ACKR1 expression in the BM, to investigate its effect on hematopoiesis and to explore the mechanism leading in the absence of erythroid ACKR1 to neutropenia.
RESULTS

ACKR1 is highly expressed by nucleated erythroid cells
We used a new monoclonal antibody specific for mouse ACKR1 (ref. 29) to map ACKR1 expression in mouse BM. Besides its expression in endothelial cells (ECs), which line BM sinusoids, ACKR1 was detected on erythroid cells but not on any other hematopoietic population (Fig. 1a-c and Supplementary Figs. 1 and 2) . We found that ACKR1 was expressed in nucleated erythroid cells (NECs)-ACKR1 expression was detected initially in pro-erythroblasts, found to peak in early normoblasts and to gradually decline to the lowest amounts in mature erythrocytes ( Fig. 1c and Supplementary Fig. 2b ). ACKR1 on NECs was functional, as fluorescently labeled CCL2, an ACKR1-cognate chemokine, bound to NEC subpopulations proportionately to the Figure 1 ACKR1 is expressed in the bone marrow by ECs and NECs. (a) Representative immunofluorescence micrograph of BM from wild-type (WT) mice after staining with antibodies to ACKR1 (yellow) and the erythroid cell marker Ly76 (also known as Ter119; red) and with DAPI (blue; nuclei) (top). Regions labeled 1-3 are magnified on the bottom. Insets, representative images (of at least 20 taken) showing ACKR1 immunoreactivity in sinusoidal ECs (arrows), anuclear mature erythrocytes (arrowheads) and NECs (asterisks). Scale bars, 30 µm (top) and 15 µm (inset). (b) Representative flow cytometry analysis of BM from WT mice (n = 6) to identify the stages of erythroid maturation: pro-erythroblasts (population I), early normoblasts (population II), intermediate normoblasts (population III), late normoblasts (population IV), reticulocytes (population V) and mature red cells (population VI), which were gated on the basis of CD71 and Ter119 expression and on forward scatter (Fsc). (c) ACKR1 expression on megakaryocyticerythroid progenitor (MEP) cells and erythroid cells (populations I-VI) in BM from WT (blue) and ACKR1-deficient (KO; red) mice. Left, representative flow cytometry histogram analysis; right, quantification of MEP and erythroid cell populations, expressed as fold change relative to MEP (n = 6 mice per group). (d) Representative flow cytometry analyses for binding of AF647-conjugated CCL2 to erythroid cells (populations I-VI) that were isolated from the BM of WT (blue) and KO (red) mice (top left) and for competition of AF647-conjugated CCL2 binding to WT erythroid cells by subsequent addition of unlabeled CXCL1 (top right). Bottom, quantification of AF647-conjugated CCL2 binding, expressed as fold change relative to the amount bound to ACKR1-deficient erythrocytes (n = 2 mice per group). *P < 0.05, **P < 0.01 and ***P < 0.001 (one-way analysis of variance (ANOVA) (c) or two-way ANOVA (d)). Data are representative of at least two independent experiments (a,b,c (left),d (bottom)) or are from two independent experiments (c,d).
A r t i c l e s levels of their ACKR1 expression ( Fig. 1d) . ACKR1 is the only chemokine receptor that binds both CCL2 and a heterologous chemokine CXCL1. We found that even after extended pre-incubation of NECs with CCL2, almost all of the NEC-bound CCL2 could be displaced by the addition of CXCL1 ( Fig. 1d) . This result suggests that ACKR1 on NECs did not internalize chemokines, which remained available on the cell surface. In summary, our data unequivocally showed that, among hematopoietic BM cells, ACKR1 was expressed only in cells of the erythroid lineage. The high level of ACKR1 expression and chemokine binding by NECs, as compared to those in mature erythrocytes, suggested that ACKR1 might have an important physiological role in the BM.
ACKR1 deficiency alters early hematopoiesis
To evaluate the contribution of ACKR1 expression to BM homeostasis, we compared parameters of hematopoiesis in ACKR1-deficient 30 and wild-type mice. We found no effect of ACKR1 expression on overall BM cellularity, number of erythroid cells, relative proportions of their individual subpopulations or any of the erythrocyte parameters in blood (Supplementary Fig. 3 ). However, ACKR1 expression had cell-extrinsic effects on the BM hematopoietic stem and progenitor cells (HSPCs). In the absence of ACKR1, the size of the lineage-negative (Lin − ) Sca-1 + c-Kit + (LSK) cell population decreased ( Fig. 2a) . This was accompanied by their reduced proliferation ( Fig. 2b) and an increase in the cell surface expression of CD34 ( Fig. 2c) . A major reduction was seen in the CD48 − subpopulation of LSKs, characterized by their self-renewing capacity ( Fig. 2d) . Furthermore, we observed shifts in the proportions of individual LSK CD48 − subpopulations in ACKR1-deficient mice, as compared to their wild-type littermates ( Fig. 2e,f) . These included an increase in the relative proportion of hematopoietic stem cells (HSCs; Fig. 2e ), although their overall numbers remained unaltered ( Fig. 2f) , as well as a relative and an absolute decrease of the CD150 − Flt3 − and CD150 − Flt3 + multipotent progenitor (MPP) 1a and MPP1b subpopulations ( Fig. 2e,f) . Furthermore, the size of the Lin − Sca-1 − c-Kit + myeloid progenitor cell (MPC) population was less in the BM from ACKR1-deficient mice than in the BM from wild-type mice ( Fig. 2g ) due to decreases in populations of CD34 + CD16/CD32 + granulocytic-monocytic progenitor (GMP) and CD34 − CD16/CD32 − megakaryocytic-erythroid progenitor (MEP) cells ( Fig. 2h,i) . Conversely, the proportions of CD34 + CD16/CD32 − common myeloid progenitor (CMP) cells and LSK CD48 + Flt3 − (MMP2) cells were greater in the BM from ACKR1-deficient mice than in the BM from wild-type mice (Fig. 2h,i and Supplementary Fig. 4b-d ), whereas the numbers of LSK CD48 + cells, lineage-restricted progenitor (LRP) cells and common lymphoid progenitor (CLP) cells remained unchanged ( Supplementary Fig. 4b,d,e ). Thus, the absence of ACKR1 resulted in numeric changes and shifts in equilibria of HSPC subpopulations and led to characteristic changes in the expression of effector molecules on their cell surface.
ACKR1 deficiency changes the HSPC transcriptome
Next we asked whether ACKR1 expression also affected the transcriptional make-up of HSPCs. To this end, LSK and GMP cells from A r t i c l e s ACKR1-deficient and their wild-type littermates were sorted by flow cytometry, and their transcriptomes were compared using a gene expression microarray. The expression for the overwhelming majority of genes were indistinguishable in corresponding cell populations from the ACKR1-deficient and wild-type mice ( Supplementary Fig. 5a,b ). Significant differences primarily included the upregulation of the same set of genes in both LSK and GMP cells from ACKR1-deficient mice ( Fig. 3a and Supplementary Fig. 5c ), with the majority of these transcripts ascribed to be neutrophil or myeloid specific ( Fig. 3b and Supplementary Fig. 5d ). Some of the transcripts of genes encoding neutrophil-specific effector molecules, including those encoding cathelicidin, neutrophil granule protein and resistin-like molecule γ, were increased 1,000-fold or more in GMPs from the BM of ACKR1deficient mice ( Supplementary Fig. 5b ), although the transcripts from the upregulated genes represented only a part of the characteristic neutrophil transcriptome and excluded some classical neutrophil markers ( Fig. 3c) . Thus, the absence of ACKR1 led to an upregulation of a subset of neutrophil and other mature-cell-specific transcripts in HSPCs, findings that were consistent with the altered differentiation of HSPCs. Together with the observed numeric and surface molecule changes in HSPC subsets, these data indicated that ACKR1 expression massively affected the balanced BM homeostasis of HSPCs.
ACKR1 on bone marrow NECs affects HSPCs
In the BM, ACKR1 is expressed by sinusoidal ECs and NECs. Vessels in the BM serve as a HSPC niche [31] [32] [33] , whereas NECs have not previously been shown to affect HSPC homeostasis. To explore whether the HSPC changes observed in ACKR1-deficient mice were due to the lack of ACKR1 expression in ECs, NECs or both, HSPC parameters were recorded in reciprocal irradiation BM chimeric wild-type and ACKR1-deficient mice. Mice in individual groups expressed ACKR1 in the hematopoietic or stromal compartment, or in both, or either were globally deficient in ACKR1 expression ( Supplementary Fig. 6a-c) .
The characteristic for the ACKR1-deficient mice shifts in the HSPC populations and changes in the expression of CD34 on LSK cells were observed in chimeric mice, which lacked ACKR1 expression in the hematopoietic but not stromal compartment ( Fig. 4a-c and Supplementary Fig. 6d ). These data clearly pinpointed ACKR1 expression in erythroid cells as a regulator of HSPC homeostasis.
Next we asked whether the ACKR1 expressed by circulating erythrocytes or by BM NECs might have an effect on HSPCs. To this end, we created parabiotic wild-type and ACKR1-deficient mouse pairs, which shared a common blood circulation but maintained their distinct tissue microenvironments, including those in the BM (Supplementary Fig. 6e ). ACKR1 on wild-type erythrocytes present within the common circulation restored the plasma concentrations of cognate chemokines in ACKR1-deficient parabionts ( Supplementary Fig. 6f ) but failed to affect the characteristic overexpression of CD34 and the disbalance of HSPC populations in the BM of ACKR1-deficient parabionts (Fig. 5a-c and Supplementary Fig. 6g ). Collectively, our data on ACKR1 expression in BM together with the findings in the reciprocal BM chimeric and parabiotic mice showed that ACKR1 expressed on BM NECs regulated in trans-geometry the homeostasis of HSPCs.
ACKR1 on NECs promotes their direct interactions with HSCs
NECs are ubiquitous BM cells that might interact directly with HSCs and thus affect their behavior. Two-photon microscopy analysis of whole-mount BM preparations allowed the unequivocal detection of NECs and HSCs ( Supplementary Fig. 7a,b ) and showed that the NECs formed immediate contacts with the majority of the HSCs present in the BM from wild-type mice ( Fig. 6a) . ACKR1 facilitated the establishment of these close cell encounters, as only a third of all HSCs directly interacted with NECs in BM from ACKR1-deficient mice ( Fig. 6b) , whereas the majority were localized at some distance from the NECs ( Fig. 6c and Supplementary Fig. 7c ). The direct interactions between the HSCs and NECs were sufficiently avid to register as cell duplets in flow cytometry analyses, which also revealed that there was a higher proportion of NEC-HSC duplets in the BM from wild-type
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Gene expression activity (%) A r t i c l e s mice than that in the BM from ACKR1-deficient mice (Fig. 6d) .
Flow cytometry analyses showed that MMP1, MPP2 and LRP cells also formed direct contacts with NECs; however, only MMP1 and LRP cells, but not MPP2 cells required the presence of ACKR1 on NECs to establish the direct cell contacts (Supplementary Fig. 7d) . These data described a previously unknown direct interaction between NECs and HSPCs and uncovered the unexpected role that ACKR1 has in their formation. Taken together with the observed effect of the ACKR1 deficiency on HSPCs, our data suggest that NECs are directly involved in regulating the early stages of hematopoiesis and that an ACKR1 deficiency in the erythroid lineage can broadly affect the phenotypes of BM-derived cells.
ACKR1 deficiency alters neutrophil phenotype
We used ACKR1-deficient mice to explore how the absence of ACKR1 in the erythroid lineage might affect HSPC-derived cells. Neutrophils that developed from the altered HSPCs in the BM of ACKR1-deficient mice carried a characteristic molecular signature, which notably included overexpression of Fcγ receptors (FcγRs; CD16/CD32), key molecules involved in neutrophil antimicrobial defenses 34 , and CD45, a molecule that amplifies FcγR function 35 , but not several other membrane receptors ( Fig. 7a and Supplementary Fig. 8a,b) .
A similar phenotype-overexpression of FcγRIIIb (CD16) and CD45-characterized neutrophils from healthy Duffy-negative individuals homozygous for the rs2814778(G) ACKR1 allele ( Fig. 7b) , A r t i c l e s as compared to that in neutrophils from individuals with a Duffypositive phenotype. Moreover, neutrophils from both ACKR1-deficient mice and Duffy-negative individuals selectively overexpressed CCR2 (Fig. 7c,d and Supplementary Fig. 8c,d) , a key inflammatory chemokine receptor that characterizes monocytes rather than neutrophils 1 . Thus, HSPCs that were altered in the absence of the erythroid ACKR1 gave rise to phenotypically distinct neutrophils that overexpressed a set of membrane molecules involved in host defenses. The same set of membrane effector molecules was upregulated on neutrophils of Duffy-negative individuals, suggesting that the absence of erythroid ACKR1 due to rs2814778(G) ACKR1 allele might change BM homeostasis by the same mechanism as that observed in ACKR1deficient mice.
ACKR1 regulates neutrophil counts in blood
Healthy Duffy-negative individuals of African ancestry have low blood neutrophil counts 22 . In contrast, ACKR1-deficient mice had normal neutrophil counts in blood ( Fig. 8a) and BM ( Supplementary  Fig. 8e) . Thus, the numeric reductions in the LSK subsets and GMP cells that were observed in the ACKR1-deficient mice did not directly lead to neutropenia. Also, ACKR1-deficient mice had normal numbers of all other circulating cell types, despite some numerical changes in the BM (Supplementary Fig. 8e-g) . Notably, Duffy-negative individuals who were homozygous for the rs2814778(G) ACKR1 allele lack ACKR1 on erythroid cells only but still express ACKR1 on ECs.
To explore whether such a pattern of ACKR1 expression might lead to neutropenia, we studied blood neutrophils in reciprocal wild-type and ACKR1-deficient BM chimeric mice. Wild-type mice that were reconstituted with BM from ACKR1-deficient mice had characteristically altered neutrophils (Supplementary Fig. 8h ) and were indeed neutropenic (Fig. 8b) . This finding suggests that the expression of ACKR1 in the venular compartment may contribute to neutropenia, consistent with its established function in ECs 9,36 , by facilitating neutrophil exit into the tissues. We explored this hypothesis and asked which tissues might clear the phenotypically altered neutrophils that develop in the absence of NEC-expressed ACKR1. Parabiotic wildtype and ACKR1-deficient mice allowed us to directly compare, in one artificially created organism, the homing of neutrophils from wild-type or ACKR1-deficient mice into individual ACKR1-sufficient or ACKR1-deficient tissues. Neutrophils that developed in the ACKR1-deficient BM preferentially homed into the spleens-but not other organs tested, including the BM, liver and lungs-of the wild-type parabionts (Fig. 8c) . In mice, spleen ECs of the red pulp sinusoids expressed ACKR1 (Fig. 8d) , in direct accord with the expression of ACKR1 in human spleens (Supplementary Fig. 8i) , including in Duffy-negative individuals 27 . It is not clear whether the altered neutrophils that migrated into the spleen could persist there and contribute to the splenic host defenses. Alternatively, the migration of neutrophils into the spleen that was dependent on EC-expressed ACKR1 might be part of their clearance from the circulation, akin to the mechanism described for neutrophils homing into the BM 37 . Thus, we showed that altered neutrophils, which developed in the absence of ACKR1 on NECs, left the circulation thereby causing neutropenia; however, this occurred only when ACKR1 was expressed by venular ECs, a pattern of ACKR1 expression that was mirrored in individuals of African ancestry who were homozygous for the rs2814778(G) ACKR1 allele.
DISCUSSION
Hematopoiesis is a robust process controlled by multiple molecular and cellular cues that maintain HSPCs and regulate their differentiation and proliferation for consistent BM cell outputs 32, 33 . Here we show that the ACKR1 expressed by NECs, the most ubiquitous BM cells, regulates the homeostasis of HSPCs and modifies downstream hematopoiesis. The absence of ACKR1 led to altered numbers of HSPCs, A r t i c l e s which was due, in part, to their decreased proliferation. It also resulted in shifts in proportions of individual HSPC subpopulations, changes in HSPC transcriptomes and altered expression of their functional surface molecules. The overall BM cellularity was not affected by ACKR1, and the numeric changes in the individual subpopulations of HSPCs seemed discordant. The number of HSCs, the BM's 'reserve' population 38, 39 , was not affected. However, the immediate downstream population, MPP1a cells, was reduced, and MPP1b cells were practically absent from the BM of ACKR1-deficient mice. This was accompanied by an increase in CMP cells, a population downstream of MPP1 cells, which might have resulted from accelerated differentiation of MPP1 cells to CMP cells. Alternatively, the numerically increased CMP cells may have derived from MPP2 populations, which were also increased in the BM of ACKR1-deficient mice, suggesting either a potential contribution of alternative progenitor clones present in the BM 40 or pathway plasticity of early HSPC differentiation 41 . It is possible that changes in the expression of the molecular markers that were used to define the HSPC subpopulations might have contributed to the numeric differences observed in the BM from ACKR1-deficient mice. Experiments in ACKR1-deficient chimeric and parabiotic mice unequivocally established that HSPCs were affected by ACKR1 expression on NECs but not by ACKR1 expression on ECs or circulating erythrocytes. Furthermore, the expression of ACKR1 by NECs increased direct cell contacts between HSPC populations and NECs. These data suggest that ACKR1 determines the function of a HSPC niche that is associated with NECs, the existence of which has not been recognized previously. Currently it is not clear whether ACKR1 only mediates the interaction of NECs and HSPCs, whereas another putative NEC molecule signals to HSPCs. Alternatively, ACKR1 might directly signal to HSPCs, for example, by involving the tetraspanin family member CD82, which has been suggested to bind ACKR1 in trans geometry 42 . Recently, CD82 on HSCs has been implicated in maintaining their quiescence through interaction with ACKR1, which was detected spuriously on BM macrophages using a nonvalidated antibody to ACKR1 (ref. 43) . Indeed, high concentrations of this antibody stained BM macrophages, albeit equally well in WT and ACKR1-deficient mice. On the basis of immunostaining studies using a specific antibody and a transcriptomic analysis, ACKR1 is not expressed on macrophages in the BM or in other tissues 29 . Nevertheless, it is possible that CD82, either in trans on HSPCs or through a cis interaction in NECs, might contribute to the effects of ACKR1 on HSPCs. Alternatively, the ACKR1-dependent signal to HSPCs involves one or several of more than 20 chemokine ligands for ACKR1 (ref. 13) . We showed that ACKR1 on NECs binds, but does not scavenge, cognate chemokines, and it may thus function as a BM reservoir and a universal immobilization template for cognate chemokines. Such function might enable the retention of ACKR1 ligands in NEC-rich microenvironments, thus allowing these chemokines to signal via GPCRs to HSPCs and other BM cells. The chemokine presentation template, ACKR1 on NECs, remains constant, but the signals to HSPCs might change depending on the individual chemokines immobilized and their endless potential combinations that characterize different physiological and pathological conditions. Several of the ACKR1-cognate chemokines have been shown to affect HSPCs and hematopoiesis 44 , although CXCL12, which has a key role in HSPC homeostasis 45 , does not bind ACKR1 (ref. 46) .
The absence of ACKR1 caused a shift in the HSPC transcriptome that resulted in a massive overexpression of a subset of neutrophiland myeloid-specific genes. This is consistent with an altered differentiation pattern of HSPCs toward the myeloid lineage and suggests that the characteristic molecular signature of neutrophils that is observed in the context of an ACKR1 deficiency might already be imprinted during the early steps of hematopoiesis. The signature changes in neutrophils that originated in the BM from ACKR1deficient mice were required, but not sufficient alone, to cause neutropenia. The BM chimeric mice showed that neutropenia developed only when the absence of ACKR1 in the BM was combined with the expression of ACKR1 in the venular ECs. Mechanistically this is consistent with the known contribution of ACKR1 on ECs to optimal chemokine-driven neutrophil egress into tissues 9 , and it explains why mice with a global ACKR1 deficiency, despite having altered neutrophils, were not neutropenic. Accordingly, in parabiosis experiments the emigration of the phenotypically altered neutrophils of the ACKR1-deficient parabionts took place preferentially into the spleens of wild-type mice. In addition to the spleen, venular ECs in several other organs and tissues, including the skin and the gut, but not the liver or the lungs, express ACKR1 (ref. 29 ). Thus, neutrophils that develop in the absence of ACKR1 on NECs might also exit the circulation into the skin, gut and other tissues. Although BM sinusoids expressed ACKR1, they did not support the preferential homing of altered neutrophils. This might be explained by findings that neutrophils use an alternative chemokine pathway for their homing to the BM, involving CXCR4 and its ligand CXCL12 (ref. 37) , which is not an ACKR1-cognate chemokine 46 .
Our findings on the peculiarities of hematopoiesis that take place in the absence of ACKR1 on NECs are highly relevant for human health, as Duffy-negative individuals of African ancestry selectively lack ACKR1 expression in the cells of the erythroid lineage only, whereas ACKR1 is expressed in ECs 25 . Neutrophils of the Duffynegative individuals mirror the distinct molecular signature of neutrophils in ACKR1-deficient mice. We suggest that these altered neutrophils in humans also readily leave circulation, thus leading to neutropenia that is associated with the ACKR1 rs2814778(G) polymorphism 23 . It is conceivable that the differential signature pattern of molecular effectors on neutrophils has provided Duffynegative individuals with a natural selective advantage for superior innate responses to microbial pathogens. Selective pressure by a broad range of infectious agents, together with the known partial resistance of Duffy-negative individuals to P. vivax malaria 47, 48 , may have contributed to the selection and fixation of the ACKR1 rs2814778(G) polymorphism in almost the entire population of sub-Saharan Africa 25 .
In summary, we show that the absence of ACKR1 on cells of the erythroid lineage changes steady-state hematopoiesis, and alternative physiological patterns of hematopoiesis exist depending on ACKR1 expression in the erythroid lineage. It will be intriguing to elucidate how ACKR1 expression by NECs affects emergency hematopoiesis and BM responses in infection, inflammation, injury and cancer.
METHODS
Methods, including statements of data availability and any associated accession codes and references, are available in the online version of the paper.
Note: Any Supplementary Information and Source Data files are available in the online version of the paper.
Reciprocal irradiation BM chimeric mice. BM cells from either C57BL/6 (WT) or ACKR1-deficient (KO) mice were harvested and transplanted into lethally irradiated (9 Gy) WT or ACKR1-deficient recipients by tail vein injection of 10 7 cells in 200 µl PBS, thus creating four experimental groups. Recipients received prophylactic endofloxacin (Baytril, Bayer AG) for 1 week before and also after irradiation. Eight weeks after the BM transfer, the recipients were culled. BM and blood cells were collected, washed and stained to identify HSPCs and PMNs, respectively, as described above. The degree of donor chimerism was established by measuring the expression of ACKR1 on BM NECs and blood erythrocytes with an antibody to mouse ACKR1 ( Supplementary Table 1 ). In addition, CD45.1 and CD45.2 staining showed that all of the BM HSPCs and blood PMNs in the irradiated recipients were replaced by donor cells.
Parabiosis.
To generate parabiotic pairs, we followed published protocols 49 . Briefly, anesthetized mice were shaved at the corresponding lateral aspects, matching skin incisions were made from the olecranon to the knee joint of each mouse, and the subcutaneous fascia was bluntly dissected to create about 0.5 cm of free skin. The olecranon and knee joints were attached by a single 5-0 polypropylene suture and tie, and the dorsal and ventral skins were approximated by continuous suture. A single dose of flunixin meglumine (Schering-Plough) was injected subcutaneously in each partner at the end of the surgical procedure (1 mg per kg body weight). WT-WT, KO-KO and WT-KO pairs were created. One month after surgery, blood and BM were obtained from each of the partners for analysis of the hematopoietic progenitors.
In another experiment in which the homing of neutrophils was studied, different parabiotic pairs were used: WT-WT pairs (CD45.1 and CD45.2) and WT-KO pairs (CD45.1 and CD45.2, respectively). One month after surgery, blood, BM, spleen, lung and liver samples were obtained from each of the partners for analysis of neutrophils. The percentage of neutrophils from partner parabionts (percentage chimerism) was defined on gated neutrophils in blood, BM, lung, liver and spleen. Migration indices were calculated for each tissue as the percentage chimerism in a specific tissue divided by the percentage chimerism in blood, and these were normalized by using the values obtained in the WT-WT control pairs. Cell sorting. The BM of WT or ACKR1-deficient mice was flushed; cells were pooled from three mice and stained for lineage markers, CD34, CD16/CD32, cKit and Sca-1 in 500 µl buffer, for 1 h on ice. Cells were sorted on a Mo-flow MultiLaser flow cytometer (Beckman Coulter). First, an enrichment step was performed, with gates set based on forward-and side-scatter characteristics for lineage-negative and either GMP cells or LSK cells. The GMP and LSK populations then underwent a second sorting step using the same gating profiles. The twice-sorted GMP and LSK populations, which were determined to be more than 97% pure, were snap-frozen on dry ice for storage at −80 °C until use.
Microarray and analysis. RNA was extracted from sorted GMP and LSK populations using Trizol (Life Technologies) as per the manufacturer's directions. An RNA sample (25 ng) was labeled with the Cy3 dye as per the protocol detailed in the Low Input Quick Amp Labeling Kit (Agilent Technologies). A specific activity of >6.0 was confirmed by A 260nm and A 550nm measurements using a NanoDrop ND-1000 spectrophotometer. Labeled RNA (600 ng) was hybridized to Agilent SurePrint G3 mouse 8 × 60K microarray slides for 16 h. Slides were washed and scanned with a High-Resolution C Scanner (Agilent Technologies), using a scan resolution of 3 µm. Feature extraction was performed using Agilent Feature Extraction software, with no background subtraction. Scanned microarray images were analyzed using Agilent's Feature Extraction software. Feature intensities were background-subtracted according to the normal-exponential convolution model and normalized using 75th percentile normalization. Differentially expressed genes were identified using the significant analysis of microarrays (SAM) method with a false discovery rate (FDR) <0.05 using Multiexperiment Viewer (MeV) software (http://www. tm4.org/mev.html). Hierarchical clustering was obtained using Gene Cluster 3.0 software.
To ascribe characteristic profiles to the set of genes that were differentially expressed in the microarray analysis, the specificity of genes upregulated in both LSK and GMP cells from KO mice, which was defined as cluster 1, was determined based on their annotation in Gene Expression Commons (GEXC) 50 . Briefly, the gene expression activity files of all of the BM cells were downloaded from GEXC (https://gexc.riken.jp), aligned with those of the 69 genes of cluster 1 that were retrieved, and the heat maps of their expression activity were created for individual cell populations. The analysis showed enrichment primarily in PMN-specific genes. To determine whether such enrichment was selective for a subset or PMN-specific genes, the expression of all genes that were annotated as being PMN specific in the Immgen database (http://www.immgen.org/) was assessed in the microarray. Briefly, among 334 defined cell-specific clusters in the Immgen "Modules and Regulators" tool, three modules (209, 210 and 258) have been assigned as PMN-specific and encompass 54 genes in total (22, 11 and 12 genes, respectively). The expression of these genes was verified in the microarray and presented for individual modules as heat maps.
Two-photon laser scanning microscopy (TPLSM) of the whole-mounted bone marrow.
Mice were euthanized and perfused via cardiac puncture with 3 ml cold PBS followed by 3 ml cold 4% PFA. Femurs were harvested, carefully cleaned from the surrounding tissue and post-fixed in 4% PFA at 4 °C overnight. After fixation, bones were briefly washed with PBS and cryopreserved in 15% sucrose at 4 °C for 2 h, followed by incubation in 30% sucrose at 4 °C overnight. Bones were embedded in OCT and flash-frozen. Samples were longitudinally shaved with a Leica CM3050S cryostat to expose the BM along the full length of the femur, OCT residue was washed away with PBS and nonspecific antigens were blocked by a PBS solution containing 20% normal goat serum and CD16/CD32 Fc-block (final concentration 0.5 µg/ml) for 2 h at 20 °C. Bones were incubated overnight in the dark at 20 °C with directly conjugated antibodies to the following markers: CD150, CD71 and lineage (CD3, B22, Gr1, CD11b, CD48, CD41). After incubation, the bones were washed several times with PBS and embedded into PBS-based 1.5% agarose gel before imaging. Further details regarding imaging reagents are provided in Supplementary Table 1 .
Four-color TPLSM microscopy was performed on a Leica SP5IIMP that was equipped with a 20× NA1.00 WD objective (Leica) and a pre-chirped MaiTai Ti:Sa pulsed laser (Spectra-Physics) tuned at 800 nm to maximize dye emission. Optical zoom was applied where applicable. To allow for the simultaneous collection of all spectra while minimizing color spillover, the collection channels of Hybrid diode detectors were determined as follows: 380-415 nm for bonecollagen-derived second harmonic generation (SHG) signal, 420-470 nm for Pacific Blue, 500-550 nm for AF488 and 600-650 nm for phycoerythrin (PE). z-stacks (1-µm step size) of 1024 × 1024 pixel xy images (f.o.v. 356 × 356 µm 2 ) were collected up to a depth of 100-150 µm. z-stacks were three dimensionally reconstructed using the Imaris software (Bitplane). HSCs were identified as CD150 + Lin − CD7 − cells, and NECs as CD71 + Lin − CD150 − cells. Both stains were rendered as isosurface, and distances between HSCs and the closest NECs were determined using the software's measurement tools.
Human blood samples. Blood was collected from healthy individuals as approved by the ethical committee of LMU, Munich following written consent. To determine the expression of Duffy antigen on erythrocytes, whole blood was stained with mouse monoclonal anti-ACKR1 (Fy6, gift from Dr. M. Uchikawa), washed and stained with a FITC-conjugated secondary antibody ( Supplementary Table 1 ). For staining of neutrophil surface markers, erythrocytes were lysed using ACK lysing buffer, and the remaining cells were washed with FACS buffer. Cells were incubated with antibodies to CD45, CD11b, CD16, CXCR1, CXCR2 and CCR2 and analyzed using a FACS CANTO II flow cytometer.
Statistical analysis.
Multiple independent experiments were performed to verify the reproducibility of the experimental findings. When suitable, sample sizes were estimated based on results of explorative experiments to provide adequate power. No randomization or blinding was used for any of the experiments. Mice were excluded from experiments if they showed any signs of sickness. Differences in two-group comparisons were assessed by an unpaired Student's t-test, with Welch's correction when appropriate. Comparisons between three or more groups were performed by one-way or two-way ANOVA as appropriate, followed by a Tukey's post hoc test.
